Skip to main content
Clinical Trials/NCT05703958
NCT05703958
Recruiting
N/A

An Open Label, Multi-Center, Retrospective and Prospective Evaluation of Equinoxe Proximal Humerus Fracture Plates Clinical and Radiographic Outcomes

Exactech1 site in 1 country151 target enrollmentApril 19, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Proximal Humeral Fracture
Sponsor
Exactech
Enrollment
151
Locations
1
Primary Endpoint
Sane Score
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The objective of this study is to collect and evaluate long-term clinical outcomes data in order to better understand the safety and performance of the Equinoxe Proximal Humerus Fracture Plates over time. This study will follow subjects for a period of up to 10 years post-surgery.

Registry
clinicaltrials.gov
Start Date
April 19, 2023
End Date
September 30, 2034
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Exactech
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient is indicated to receive Equinoxe Proximal Humerus Fracture Plate or has previously underwent primary surgery with Equioxe Proximal Humerus Fracture Plate
  • Patient is willing to participate by complying with pre- and postoperative visit requirements
  • Patient is willing to agree to be followed for up to 10 years following their index surgery
  • Patient is willing and able to review and sign a study informed consent form

Exclusion Criteria

  • Osteomyelitis of the proximal humerus or scapula
  • Inadequate or malformed bone that precludes adequate support or fixation of the prosthesis
  • Patient's age, weight, or activity level would cause the surgeon to expect early failure of the system
  • The patient is unwilling or unable to comply with the post-operative care instructions
  • Alcohol, drug, or other subtance abuse
  • Any disease state that could adversaly affect the function or longevity of the implant
  • Patient is pregnant
  • Patient is a prisoner
  • Patient has a physical or mental condition that would invalidate the results

Outcomes

Primary Outcomes

Sane Score

Time Frame: Through study completion, an average of 1 per year

Single Assessment Numeric Evaluation (SANE) - Patient shoulder self-evaluation as a percentage of normal, 100% corresponds being normal

ASES

Time Frame: Through study completion, an average of 1 per year

American Shoulder and Elbow Surgeons Score (ASES) - 100 points scale about shoulder pain and performance evaluation in activities of daily living where 100 indicates the best shoulder condition

Quick DASH

Time Frame: Through study completion, an average of 1 per year

Shorten version of Disability of the Arm, Shoulder, and Hand (DASH) - 11 items to measure ability of a patient to perform certain upper extremity where 0 corresponds to no difficulty and 100 corresponds to unable

Smart Score

Time Frame: Through study completion, an average of 1 per year

Shoulder Arthroplasty Smart (SAS) score - 6 questions based on 3 objective active range of motion and 3 subjective measures of pain and function. Score range of 0 to 100 where 100 indicates the best score

Study Sites (1)

Loading locations...

Similar Trials